S. COLIN NEILL

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

GT Biopharma, Inc.

Filing Date Source Excerpt
2004-04-29 S. Colin Neill Age: 57 Director. Mr. Neill was appointed to the Board of Directors as part of the Understanding described above in the section of this Proxy Statement entitled Change In Control. ... After the resignations of Messrs. Wolf and Pryor, the Board of Directors appointed Mr. Neill and Gerard J. Vlak, Ph.D. as new members of this Committee, such that the Committee is currently comprised of Mr. Davis (Chair), Mr. Neill and Dr. Vlak. ... After the resignations of Messrs. Wolf and Ford Webb, the Board of Directors appointed Dr. Bruinsma and Mr. Neill as new members of this Committee, such that the Committee is currently comprised of Dr. Bruinsma (Chair), Mr. Neill and Dr. Rodell.
2005-04-29 S. Colin Neill 58 Secretary and Director* * Member of the Nominating Committee, and serves on the Audit Committee as the Company’s designated audit committee financial expert.
2006-06-15 S. Colin Neill (1) (3) 60 Secretary, Director 2004 (1) Member of the Audit Committee (3) Member of the Nominating Committee
2007-09-19 S. Colin Neill (1) (3) 61 Secretary, Director 2004 (1) Member of the Audit Committee (3) Member of the Nominating Committee ... Total $17,858

Data sourced from SEC filings. Last updated: 2025-08-30